7 Recruiting Pancreatic Cancer Phase 3 Clinical Trials
Active phase 3 studies for pancreatic cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Pancreatic Cancer studiesPhase 3 Studies for Pancreatic Cancer
🔵 Active, Not Recruiting Phase3
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase3
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
📍 The University of Arizona Cancer Center-North Campus — Tucson, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
📍 Clearview Cancer Institute — Huntsville, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
📍 University of Arizona Cancer Center - North Campus — Tucson, Arizona
View Study & Checklist ➔